Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenichi Gemba

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Acta Oncologica (Stockholm, Sweden)|October 18, 2005
Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experienceKatsuyuki Hotta, Hiroshi Ueoka, Katsuyuki Kiura, et al.
Carcinogenesis|July 18, 2008
Aberrant promoter hypermethylation in serum DNA from patients with silicosisShigeki Umemura, Nobukazu Fujimoto, Akio Hiraki, et al.
International Journal of Clinical Oncology|March 28, 2016
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinolKazuo Tamura, Yasukazu Kawai, Toru Kiguchi, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2004
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patientsNagio Takigawa, Yoshihiko Segawa, Daizo Kishino, et al.
Cancer Chemotherapy and Pharmacology|April 1, 2016
Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experienceKenichiro Kudo, Katsuyuki Hotta, Akihiro Bessho, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2006
A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II studyMasahiro Tabata, Toshiyuki Kozuki, Hiroshi Ueoka, et al.
Lung Cancer (Amsterdam, Netherlands)|December 6, 2008
A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancerKenichi Chikamori, Daizo Kishino, Nagio Takigawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Triple combination chemotherapy with cisplatin, docetaxel, and irinotecan for advanced non-small cell lung cancer: a phase I/II trialKatsuyuki Kiura, Nagio Takigawa, Yoshihiko Segawa, et al.
Cancer Journal (Sudbury, Mass.)|November 2, 2005
Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study GroupKatsuyuki Hotta, Katsuyuki Kiura, Masahiro Tabata, et al.
Lung Cancer (Amsterdam, Netherlands)|May 11, 2010
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancerNagio Takigawa, Katsuyuki Kiura, Katsuyuki Hotta, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Acta Oncologica (Stockholm, Sweden)|October 18, 2005
Safety and efficacy of gefitinib treatment in elderly patients with non-small-cell lung cancer: Okayama Lung Cancer Study Group experienceKatsuyuki Hotta, Hiroshi Ueoka, Katsuyuki Kiura, et al.
Carcinogenesis|July 18, 2008
Aberrant promoter hypermethylation in serum DNA from patients with silicosisShigeki Umemura, Nobukazu Fujimoto, Akio Hiraki, et al.
International Journal of Clinical Oncology|March 28, 2016
Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinolKazuo Tamura, Yasukazu Kawai, Toru Kiguchi, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2004
Clinical and pharmacokinetic study of docetaxel in elderly non-small-cell lung cancer patientsNagio Takigawa, Yoshihiko Segawa, Daizo Kishino, et al.
Cancer Chemotherapy and Pharmacology|April 1, 2016
Development of a skin rash within the first week and the therapeutic effect in afatinib monotherapy for EGFR-mutant non-small cell lung cancer (NSCLC): Okayama Lung Cancer Study Group experienceKenichiro Kudo, Katsuyuki Hotta, Akihiro Bessho, et al.
Cancer Chemotherapy and Pharmacology|September 30, 2006
A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II studyMasahiro Tabata, Toshiyuki Kozuki, Hiroshi Ueoka, et al.
Lung Cancer (Amsterdam, Netherlands)|December 6, 2008
A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancerKenichi Chikamori, Daizo Kishino, Nagio Takigawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Triple combination chemotherapy with cisplatin, docetaxel, and irinotecan for advanced non-small cell lung cancer: a phase I/II trialKatsuyuki Kiura, Nagio Takigawa, Yoshihiko Segawa, et al.
Cancer Journal (Sudbury, Mass.)|November 2, 2005
Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study GroupKatsuyuki Hotta, Katsuyuki Kiura, Masahiro Tabata, et al.
Lung Cancer (Amsterdam, Netherlands)|May 11, 2010
A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancerNagio Takigawa, Katsuyuki Kiura, Katsuyuki Hotta, et al.
Pageof 6